Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis
Background and objective Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple‐breath washout (N2‐MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical proper...
Gespeichert in:
Veröffentlicht in: | Respirology (Carlton, Vic.) Vic.), 2018-08, Vol.23 (8), p.764-770 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 770 |
---|---|
container_issue | 8 |
container_start_page | 764 |
container_title | Respirology (Carlton, Vic.) |
container_volume | 23 |
creator | Nyilas, Sylvia Schreder, Theresa Singer, Florian Poellinger, Alexander Geiser, Thomas Kurt Latzin, Philipp Funke, Manuela |
description | Background and objective
Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple‐breath washout (N2‐MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical properties of N2‐MBW in IPF.
Methods
In this prospective cohort pilot study, 25 IPF patients and 25 healthy controls were assessed at baseline and 10 patients at median 6.2 months later. Outcomes included the lung clearance index (LCI) from N2‐MBW, forced vital capacity (FVC) from spirometry, diffusion capacity of the lungs for carbon monoxide (DLCO), bronchiectasis score from computed tomography scans, the Gender–Age–Physiology (GAP score for IPF) stage and death or lung transplantation (LTx). Study end points were feasibility, repeatability, discriminative capacity and correlation with disease severity and structural lung damage.
Results
All patients were able to perform N2‐MBW. LCI was repeatable and reproducible. Median (interquartile range (IQR)) LCI in IPF was 11.6 (10.1–13.8) in IPF versus 7.3 (6.9–8.4) in controls (P < 0.0001). LCI correlated with DLCO corrected for haemoglobin (corrDLCO; r = −0.49, P = 0.016), bronchiectasis score (r = 0.45, P = 0.024) and the GAP stage (r = 0.59, P = 0.002), but not with FVC. FVC was not related to bronchiectasis. During follow‐up, six patients died and one received LTx. LCI correlated with the latter compound outcome: hazard ratio (95% CI) was 2.43 (1.26; 4.69) per one LCI SD from the patient population.
Conclusion
N2‐MBW is a feasible, reliable and valid lung function test in IPF. LCI correlates with diffusion impairment, structural airway damage and clinical disease severity. LCI is a promising surveillance tool in IPF that may predict mortality.
In this pilot study, we demonstrate that nitrogen‐multiple breath washout (N2‐MBW) is a feasible, sensitive and reproducible lung function test in patients with idiopathic pulmonary fibrosis. The N2‐MBW‐derived lung clearance index correlates with clinical disease severity, structural airway pathology and mortality.
See related Editorial |
doi_str_mv | 10.1111/resp.13294 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2018028423</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2069955626</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3934-5037b2c2cc65eb7c89a6ecfb91bbaf0044b72f314bd54ebdcbc299a81443e6103</originalsourceid><addsrcrecordid>eNp9kUlLLDEUhYM8cd74Ax6BtxGhNFMNcdeIEyiKw7pIUik7Up2USYXGf-_V1rdwYRbJJXwczrkHoX1Kjiic42jTeEQ5k2INbVEhSEEbwf_AzBkv6lrKTbSd0gshhJek3ECbTJY1jHILhZs8TG4cLNbRqmmOlyrNQ55O8Ax7u8TKd3iMYeGS8894yHD12ZvJBY8nmybch4hHNTnrp4SXDhRc5wL8zJ3BYx4Wwav4hnunY0gu7aL1Xg3J7n29O-jp_Ozx9LK4vr24Op1dF4ZLLoqS8Fozw4ypSqtr00hVWdNrSbVWPSFC6Jr1nArdlcLqzmjDpFQNpOe2ooTvoIOVLph_zWC0hQjGDoPyNuTUMkIbwhrBOKD_fqAvIUcP7oCqpCzLilVAHa4oAzlStH07RreAaC0l7UcN7UcN7WcNAP_9ksx6Ybv_6PfeAaArYOkG-_aLVHt_9nC3En0H1eCUYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2069955626</pqid></control><display><type>article</type><title>Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Nyilas, Sylvia ; Schreder, Theresa ; Singer, Florian ; Poellinger, Alexander ; Geiser, Thomas Kurt ; Latzin, Philipp ; Funke, Manuela</creator><creatorcontrib>Nyilas, Sylvia ; Schreder, Theresa ; Singer, Florian ; Poellinger, Alexander ; Geiser, Thomas Kurt ; Latzin, Philipp ; Funke, Manuela</creatorcontrib><description>Background and objective
Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple‐breath washout (N2‐MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical properties of N2‐MBW in IPF.
Methods
In this prospective cohort pilot study, 25 IPF patients and 25 healthy controls were assessed at baseline and 10 patients at median 6.2 months later. Outcomes included the lung clearance index (LCI) from N2‐MBW, forced vital capacity (FVC) from spirometry, diffusion capacity of the lungs for carbon monoxide (DLCO), bronchiectasis score from computed tomography scans, the Gender–Age–Physiology (GAP score for IPF) stage and death or lung transplantation (LTx). Study end points were feasibility, repeatability, discriminative capacity and correlation with disease severity and structural lung damage.
Results
All patients were able to perform N2‐MBW. LCI was repeatable and reproducible. Median (interquartile range (IQR)) LCI in IPF was 11.6 (10.1–13.8) in IPF versus 7.3 (6.9–8.4) in controls (P < 0.0001). LCI correlated with DLCO corrected for haemoglobin (corrDLCO; r = −0.49, P = 0.016), bronchiectasis score (r = 0.45, P = 0.024) and the GAP stage (r = 0.59, P = 0.002), but not with FVC. FVC was not related to bronchiectasis. During follow‐up, six patients died and one received LTx. LCI correlated with the latter compound outcome: hazard ratio (95% CI) was 2.43 (1.26; 4.69) per one LCI SD from the patient population.
Conclusion
N2‐MBW is a feasible, reliable and valid lung function test in IPF. LCI correlates with diffusion impairment, structural airway damage and clinical disease severity. LCI is a promising surveillance tool in IPF that may predict mortality.
In this pilot study, we demonstrate that nitrogen‐multiple breath washout (N2‐MBW) is a feasible, sensitive and reproducible lung function test in patients with idiopathic pulmonary fibrosis. The N2‐MBW‐derived lung clearance index correlates with clinical disease severity, structural airway pathology and mortality.
See related Editorial</description><identifier>ISSN: 1323-7799</identifier><identifier>EISSN: 1440-1843</identifier><identifier>DOI: 10.1111/resp.13294</identifier><identifier>PMID: 29573509</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Adult ; Aged ; Breath Tests ; Bronchiectasis ; Bronchiectasis - diagnostic imaging ; Carbon Monoxide ; Computed tomography ; Feasibility studies ; Female ; Fibrosis ; Hemoglobin ; Humans ; idiopathic pulmonary fibrosis ; Idiopathic Pulmonary Fibrosis - physiopathology ; Idiopathic Pulmonary Fibrosis - surgery ; interstitial lung disease ; lung clearance index ; Lung diseases ; lung fibrosis ; Lung Transplantation ; Male ; Middle Aged ; multiple breath washout ; Nitrogen ; Parenchyma ; Pilot Projects ; Prospective Studies ; Pulmonary Diffusing Capacity ; Pulmonary fibrosis ; Pulmonary Ventilation ; Reproducibility of Results ; Respiratory diseases ; Respiratory function ; Respiratory tract diseases ; Severity of Illness Index ; Tidal Volume ; Tomography, X-Ray Computed ; Vital Capacity ; Young Adult</subject><ispartof>Respirology (Carlton, Vic.), 2018-08, Vol.23 (8), p.764-770</ispartof><rights>2018 Asian Pacific Society of Respirology</rights><rights>2018 Asian Pacific Society of Respirology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3934-5037b2c2cc65eb7c89a6ecfb91bbaf0044b72f314bd54ebdcbc299a81443e6103</citedby><cites>FETCH-LOGICAL-c3934-5037b2c2cc65eb7c89a6ecfb91bbaf0044b72f314bd54ebdcbc299a81443e6103</cites><orcidid>0000-0003-1840-3118</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fresp.13294$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fresp.13294$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29573509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nyilas, Sylvia</creatorcontrib><creatorcontrib>Schreder, Theresa</creatorcontrib><creatorcontrib>Singer, Florian</creatorcontrib><creatorcontrib>Poellinger, Alexander</creatorcontrib><creatorcontrib>Geiser, Thomas Kurt</creatorcontrib><creatorcontrib>Latzin, Philipp</creatorcontrib><creatorcontrib>Funke, Manuela</creatorcontrib><title>Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis</title><title>Respirology (Carlton, Vic.)</title><addtitle>Respirology</addtitle><description>Background and objective
Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple‐breath washout (N2‐MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical properties of N2‐MBW in IPF.
Methods
In this prospective cohort pilot study, 25 IPF patients and 25 healthy controls were assessed at baseline and 10 patients at median 6.2 months later. Outcomes included the lung clearance index (LCI) from N2‐MBW, forced vital capacity (FVC) from spirometry, diffusion capacity of the lungs for carbon monoxide (DLCO), bronchiectasis score from computed tomography scans, the Gender–Age–Physiology (GAP score for IPF) stage and death or lung transplantation (LTx). Study end points were feasibility, repeatability, discriminative capacity and correlation with disease severity and structural lung damage.
Results
All patients were able to perform N2‐MBW. LCI was repeatable and reproducible. Median (interquartile range (IQR)) LCI in IPF was 11.6 (10.1–13.8) in IPF versus 7.3 (6.9–8.4) in controls (P < 0.0001). LCI correlated with DLCO corrected for haemoglobin (corrDLCO; r = −0.49, P = 0.016), bronchiectasis score (r = 0.45, P = 0.024) and the GAP stage (r = 0.59, P = 0.002), but not with FVC. FVC was not related to bronchiectasis. During follow‐up, six patients died and one received LTx. LCI correlated with the latter compound outcome: hazard ratio (95% CI) was 2.43 (1.26; 4.69) per one LCI SD from the patient population.
Conclusion
N2‐MBW is a feasible, reliable and valid lung function test in IPF. LCI correlates with diffusion impairment, structural airway damage and clinical disease severity. LCI is a promising surveillance tool in IPF that may predict mortality.
In this pilot study, we demonstrate that nitrogen‐multiple breath washout (N2‐MBW) is a feasible, sensitive and reproducible lung function test in patients with idiopathic pulmonary fibrosis. The N2‐MBW‐derived lung clearance index correlates with clinical disease severity, structural airway pathology and mortality.
See related Editorial</description><subject>Adult</subject><subject>Aged</subject><subject>Breath Tests</subject><subject>Bronchiectasis</subject><subject>Bronchiectasis - diagnostic imaging</subject><subject>Carbon Monoxide</subject><subject>Computed tomography</subject><subject>Feasibility studies</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>idiopathic pulmonary fibrosis</subject><subject>Idiopathic Pulmonary Fibrosis - physiopathology</subject><subject>Idiopathic Pulmonary Fibrosis - surgery</subject><subject>interstitial lung disease</subject><subject>lung clearance index</subject><subject>Lung diseases</subject><subject>lung fibrosis</subject><subject>Lung Transplantation</subject><subject>Male</subject><subject>Middle Aged</subject><subject>multiple breath washout</subject><subject>Nitrogen</subject><subject>Parenchyma</subject><subject>Pilot Projects</subject><subject>Prospective Studies</subject><subject>Pulmonary Diffusing Capacity</subject><subject>Pulmonary fibrosis</subject><subject>Pulmonary Ventilation</subject><subject>Reproducibility of Results</subject><subject>Respiratory diseases</subject><subject>Respiratory function</subject><subject>Respiratory tract diseases</subject><subject>Severity of Illness Index</subject><subject>Tidal Volume</subject><subject>Tomography, X-Ray Computed</subject><subject>Vital Capacity</subject><subject>Young Adult</subject><issn>1323-7799</issn><issn>1440-1843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUlLLDEUhYM8cd74Ax6BtxGhNFMNcdeIEyiKw7pIUik7Up2USYXGf-_V1rdwYRbJJXwczrkHoX1Kjiic42jTeEQ5k2INbVEhSEEbwf_AzBkv6lrKTbSd0gshhJek3ECbTJY1jHILhZs8TG4cLNbRqmmOlyrNQ55O8Ax7u8TKd3iMYeGS8894yHD12ZvJBY8nmybch4hHNTnrp4SXDhRc5wL8zJ3BYx4Wwav4hnunY0gu7aL1Xg3J7n29O-jp_Ozx9LK4vr24Op1dF4ZLLoqS8Fozw4ypSqtr00hVWdNrSbVWPSFC6Jr1nArdlcLqzmjDpFQNpOe2ooTvoIOVLph_zWC0hQjGDoPyNuTUMkIbwhrBOKD_fqAvIUcP7oCqpCzLilVAHa4oAzlStH07RreAaC0l7UcN7UcN7WcNAP_9ksx6Ybv_6PfeAaArYOkG-_aLVHt_9nC3En0H1eCUYA</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Nyilas, Sylvia</creator><creator>Schreder, Theresa</creator><creator>Singer, Florian</creator><creator>Poellinger, Alexander</creator><creator>Geiser, Thomas Kurt</creator><creator>Latzin, Philipp</creator><creator>Funke, Manuela</creator><general>John Wiley & Sons, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1840-3118</orcidid></search><sort><creationdate>201808</creationdate><title>Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis</title><author>Nyilas, Sylvia ; Schreder, Theresa ; Singer, Florian ; Poellinger, Alexander ; Geiser, Thomas Kurt ; Latzin, Philipp ; Funke, Manuela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3934-5037b2c2cc65eb7c89a6ecfb91bbaf0044b72f314bd54ebdcbc299a81443e6103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Breath Tests</topic><topic>Bronchiectasis</topic><topic>Bronchiectasis - diagnostic imaging</topic><topic>Carbon Monoxide</topic><topic>Computed tomography</topic><topic>Feasibility studies</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>idiopathic pulmonary fibrosis</topic><topic>Idiopathic Pulmonary Fibrosis - physiopathology</topic><topic>Idiopathic Pulmonary Fibrosis - surgery</topic><topic>interstitial lung disease</topic><topic>lung clearance index</topic><topic>Lung diseases</topic><topic>lung fibrosis</topic><topic>Lung Transplantation</topic><topic>Male</topic><topic>Middle Aged</topic><topic>multiple breath washout</topic><topic>Nitrogen</topic><topic>Parenchyma</topic><topic>Pilot Projects</topic><topic>Prospective Studies</topic><topic>Pulmonary Diffusing Capacity</topic><topic>Pulmonary fibrosis</topic><topic>Pulmonary Ventilation</topic><topic>Reproducibility of Results</topic><topic>Respiratory diseases</topic><topic>Respiratory function</topic><topic>Respiratory tract diseases</topic><topic>Severity of Illness Index</topic><topic>Tidal Volume</topic><topic>Tomography, X-Ray Computed</topic><topic>Vital Capacity</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nyilas, Sylvia</creatorcontrib><creatorcontrib>Schreder, Theresa</creatorcontrib><creatorcontrib>Singer, Florian</creatorcontrib><creatorcontrib>Poellinger, Alexander</creatorcontrib><creatorcontrib>Geiser, Thomas Kurt</creatorcontrib><creatorcontrib>Latzin, Philipp</creatorcontrib><creatorcontrib>Funke, Manuela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Respirology (Carlton, Vic.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nyilas, Sylvia</au><au>Schreder, Theresa</au><au>Singer, Florian</au><au>Poellinger, Alexander</au><au>Geiser, Thomas Kurt</au><au>Latzin, Philipp</au><au>Funke, Manuela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis</atitle><jtitle>Respirology (Carlton, Vic.)</jtitle><addtitle>Respirology</addtitle><date>2018-08</date><risdate>2018</risdate><volume>23</volume><issue>8</issue><spage>764</spage><epage>770</epage><pages>764-770</pages><issn>1323-7799</issn><eissn>1440-1843</eissn><abstract>Background and objective
Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple‐breath washout (N2‐MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical properties of N2‐MBW in IPF.
Methods
In this prospective cohort pilot study, 25 IPF patients and 25 healthy controls were assessed at baseline and 10 patients at median 6.2 months later. Outcomes included the lung clearance index (LCI) from N2‐MBW, forced vital capacity (FVC) from spirometry, diffusion capacity of the lungs for carbon monoxide (DLCO), bronchiectasis score from computed tomography scans, the Gender–Age–Physiology (GAP score for IPF) stage and death or lung transplantation (LTx). Study end points were feasibility, repeatability, discriminative capacity and correlation with disease severity and structural lung damage.
Results
All patients were able to perform N2‐MBW. LCI was repeatable and reproducible. Median (interquartile range (IQR)) LCI in IPF was 11.6 (10.1–13.8) in IPF versus 7.3 (6.9–8.4) in controls (P < 0.0001). LCI correlated with DLCO corrected for haemoglobin (corrDLCO; r = −0.49, P = 0.016), bronchiectasis score (r = 0.45, P = 0.024) and the GAP stage (r = 0.59, P = 0.002), but not with FVC. FVC was not related to bronchiectasis. During follow‐up, six patients died and one received LTx. LCI correlated with the latter compound outcome: hazard ratio (95% CI) was 2.43 (1.26; 4.69) per one LCI SD from the patient population.
Conclusion
N2‐MBW is a feasible, reliable and valid lung function test in IPF. LCI correlates with diffusion impairment, structural airway damage and clinical disease severity. LCI is a promising surveillance tool in IPF that may predict mortality.
In this pilot study, we demonstrate that nitrogen‐multiple breath washout (N2‐MBW) is a feasible, sensitive and reproducible lung function test in patients with idiopathic pulmonary fibrosis. The N2‐MBW‐derived lung clearance index correlates with clinical disease severity, structural airway pathology and mortality.
See related Editorial</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>29573509</pmid><doi>10.1111/resp.13294</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-1840-3118</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1323-7799 |
ispartof | Respirology (Carlton, Vic.), 2018-08, Vol.23 (8), p.764-770 |
issn | 1323-7799 1440-1843 |
language | eng |
recordid | cdi_proquest_miscellaneous_2018028423 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Adult Aged Breath Tests Bronchiectasis Bronchiectasis - diagnostic imaging Carbon Monoxide Computed tomography Feasibility studies Female Fibrosis Hemoglobin Humans idiopathic pulmonary fibrosis Idiopathic Pulmonary Fibrosis - physiopathology Idiopathic Pulmonary Fibrosis - surgery interstitial lung disease lung clearance index Lung diseases lung fibrosis Lung Transplantation Male Middle Aged multiple breath washout Nitrogen Parenchyma Pilot Projects Prospective Studies Pulmonary Diffusing Capacity Pulmonary fibrosis Pulmonary Ventilation Reproducibility of Results Respiratory diseases Respiratory function Respiratory tract diseases Severity of Illness Index Tidal Volume Tomography, X-Ray Computed Vital Capacity Young Adult |
title | Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A49%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20breath%20washout:%20A%20new%20and%20promising%20lung%20function%20test%20for%20patients%20with%20idiopathic%20pulmonary%20fibrosis&rft.jtitle=Respirology%20(Carlton,%20Vic.)&rft.au=Nyilas,%20Sylvia&rft.date=2018-08&rft.volume=23&rft.issue=8&rft.spage=764&rft.epage=770&rft.pages=764-770&rft.issn=1323-7799&rft.eissn=1440-1843&rft_id=info:doi/10.1111/resp.13294&rft_dat=%3Cproquest_cross%3E2069955626%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2069955626&rft_id=info:pmid/29573509&rfr_iscdi=true |